These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 197258)

  • 21. Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.
    Tiebout RF; Sauerwein RW; van der Meer WG; van Boxtel-Oosterhof F; Zeijlemaker WP
    Immunology; 1987 Feb; 60(2):187-93. PubMed ID: 3028938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replication of latent Epstein-Barr virus genomes in Raji cells.
    Adams A
    J Virol; 1987 May; 61(5):1743-6. PubMed ID: 3033303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication.
    Weigel R; Fischer DK; Heston L; Miller G
    J Virol; 1985 Jan; 53(1):254-9. PubMed ID: 2981344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiobiological inactivation of Epstein-Barr virus.
    Henderson E; Heston L; Grogan E; Miller G
    J Virol; 1978 Jan; 25(1):51-9. PubMed ID: 202757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [IFN production by Epstein-Barr virus in human mononuclear leukocytes and suppression of the virus-induced transformation by the endogenous interferon].
    Kikuta H
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):46-57. PubMed ID: 3009290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
    Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
    Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.
    Chodosh J; Holder VP; Gan YJ; Belgaumi A; Sample J; Sixbey JW
    J Infect Dis; 1998 May; 177(5):1194-201. PubMed ID: 9593003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 30. Infection of normal human epithelial cells by Epstein-Barr virus.
    Shapiro IM; Volsky DJ
    Science; 1983 Mar; 219(4589):1225-8. PubMed ID: 6298935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus genome in infectious mononucleosis.
    Pagano JS; Huang CH; Huang YT
    Nature; 1976 Oct; 263(5580):787-9. PubMed ID: 186715
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypomethylation of Epstein-Barr virus DNA in the nonproducer B-cell line EBR.
    Larocca D; Clough W
    J Virol; 1982 Sep; 43(3):1129-31. PubMed ID: 6292457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr Virus: The Path from Latent to Productive Infection.
    Chiu YF; Sugden B
    Annu Rev Virol; 2016 Sep; 3(1):359-372. PubMed ID: 27578440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of in vitro Epstein-Barr virus infection: a new role for adult human T-lymphocytes.
    Thorley-Lawson DA; Chess L; Strominger JL
    IARC Sci Publ (1971); 1978; (24 Pt 2):623-6. PubMed ID: 221386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.
    Thorley-Lawson DA; Israelsohn ES
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5384-8. PubMed ID: 3037547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.
    Shaw JE; Levinger LF; Carter CW
    J Virol; 1979 Feb; 29(2):657-65. PubMed ID: 219253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
    Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of lymphocytes from Epstein-Barr virus-seronegative donors by autologous Epstein-Barr virus-transformed cells.
    Chang RS; Chang YY
    J Infect Dis; 1980 Aug; 142(2):156-62. PubMed ID: 6251138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular state of Epstein-Barr virus DNA in producer cell lines.
    Gussander E; Adams A
    J Gen Virol; 1979 Nov; 45(2):331-40. PubMed ID: 232128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.
    Adams A; Strander H; Cantell K
    J Gen Virol; 1975 Aug; 28(2):207-17. PubMed ID: 170370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.